166
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Subclinical Choroidal Inflammation Revealed by Indocyanine Green Angiography in Tubulointerstitial Nephritis and Uveitis Syndrome

, MD, , MD, PhD, , MD, , MD, PhD, , MD, , MD, , MD & , MD show all
Pages 1190-1198 | Received 01 Jul 2020, Accepted 21 Dec 2020, Published online: 30 Jun 2021

References

  • Dobrin RS, Vernier RL, Fish AL. Acute eosinophilic interstitial nephritis and renal failure with bone marrow-lymph node granulomas and anterior uveitis. A new syndrome. Am J Med. 1975;59(3):325‑33. doi:10.1016/0002-9343(75)90390-3.
  • Mandeville JT, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol. 2001;46(3):195‑208. doi:10.1016/S0039-6257(01)00261-2.
  • Okafor LO, Hewins P, Murray PI, Denniston AK. Tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review of its epidemiology, demographics and risk factors. Orphanet J Rare Dis. 2017;12(1):128. doi:10.1186/s13023-017-0677-2.
  • Hettinga YM, Scheerlinck LME, Lilien MR, Rothova A, De Boer JH. The value of measuring urinary β2-microglobulin and serum creatinine for detecting tubulointerstitial nephritis and uveitis syndrome in young patients with uveitis. JAMA Ophthalmol. 2015;133(2):140‑5. doi:10.1001/jamaophthalmol.2014.4301.
  • Mackensen F, Billing H. Tubulointerstitial nephritis and uveitis syndrome. Curr Opin Ophthalmol. 2009;20(6):525‑31. doi:10.1097/ICU.0b013e3283318f9a.
  • Sobolewska B, Bayyoud T, Deuter C, Doycheva D, Zierhut M. Long-term follow-up of patients with tubulointerstitial nephritis and uveitis (TINU) syndrome. Ocul Immunol Inflamm. 2018;26(4):601‑7. doi:10.1080/09273948.2016.1247872.
  • Cao JL, Srivastava SK, Venkat A, Lowder CY, Sharma S. Ultra-widefield fluorescein angiography and OCT findings in tubulointerstitial nephritis and uveitis syndrome. Ophthalmol Retina. 2019;4:189–197. doi:10.1016/j.oret.2019.08.012.
  • Reddy AK, Hwang Y-S, Mandelcorn ED, Davis JL. HLA-DR, DQ class II DNA typing in pediatric panuveitis and tubulointerstitial nephritis and uveitis. Am J Ophthalmol. 2014;157(3):678–686.e1-2. doi:10.1016/j.ajo.2013.12.006.
  • Levinson RD, Park MS, Rikkers SM, et al. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci. 2003;44(2):653‑7. doi:10.1167/iovs.02-0376.
  • Yang M, Chi Y, Guo C, Huang J, Yang L, Yang L. Ultra-wide-field fluorescence angiography findings, and long-term prognosis of uveitis in tubulointerstitial nephritis and uveitis syndrome at one tertiary medical institute in China. Ocul Immunol Inflamm. 2019;27(3):371‑9. doi:10.1080/09273948.2017.1394469.
  • Lee AR, Sharma S, Mahmoud TH. Tubulointerstitial nephritis and uveitis syndrome with a primary presentation of acute posterior multifocal placoid pigment epitheliopathy. Retin Cases Brief Rep. 2017;11(2):100‑3. doi:10.1097/ICB.0000000000000299.
  • Lecleire-Collet A, Villeroy F, Vasseneix C, Landthaler G, Brasseur G. Tubulointerstitial nephritis and uveitis syndrome (TINU syndrome) with unilateral neuroretinitis: a case report. Eur J Ophthalmol. 2004;14(4):334‑7. doi:10.1177/112067210401400410.
  • Koreishi AF, Zhou M, Goldstein DA. Tubulointerstitial nephritis and uveitis syndrome: characterization of clinical features. Ocul Immunol Inflamm. 2020;1–6. doi:10.1080/09273948.2020.1736311.
  • Ali A, Rosenbaum JT. TINU (tubulointerstitial nephritis uveitis) can be associated with chorioretinal scars. Ocul Immunol Inflamm. 2014;22(3):213–217. doi:10.3109/09273948.2013.841624.
  • Caplash S, Gangaputra S, Kodati S, Tuchman S, Srinivasalu H, Sen HN. Treatment challenges in an atypical presentation of tubulointerstitial nephritis and uveitis (TINU). Am J Ophthalmol Case Rep. 2018;10:253‑6. doi:10.1016/j.ajoc.2018.03.006.
  • Gion N, Stavrou P, Foster CS. Immunomodulatory therapy for chronic tubulointerstitial nephritis-associated uveitis. Am J Ophthalmol. 2000;129(6):764‑8. doi:10.1016/S0002-9394(00)00482-7.
  • Pakzad-Vaezi K, Pepple KL. Tubulointerstitial nephritis and uveitis. Curr Opin Ophthalmol. 2017;28(6):629‑35. doi:10.1097/ICU.0000000000000421.
  • Herbort CP. Fluorescein and indocyanine green angiography for uveitis. Middle East Afr J Ophthalmol. 2009;16:168‑87.
  • Pozdzik AA, Salmon IJ, Debelle FD, et al. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int. 2008;73(5):595–607. doi:10.1038/sj.ki.5002714.
  • Provencher LM, Fairbanks AM, Abramoff MD, Syed NA. Urinary β2-microglobulin and disease activity in patients with tubulointerstitial nephritis and uveitis syndrome. J Ophthalmic Inflamm Infect. 2018;8(1):24. doi:10.1186/s12348-018-0166-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.